- Home
- BGM vs NFJ Comparison
BGM vs NFJ Comparison
Compare BGM & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGM
- NFJ
- Stock Information
- Founded
- BGM 2019
- NFJ 2005
- Country
- BGM China
- NFJ United States
- Employees
- BGM N/A
- NFJ N/A
- Industry
- BGM
- NFJ Finance: Consumer Services
- Sector
- BGM
- NFJ Finance
- Exchange
- BGM NYSE
- NFJ Nasdaq
- Market Cap
- BGM 1.0B
- NFJ 1.2B
- IPO Year
- BGM 2021
- NFJ N/A
- Fundamental
- Price
- BGM $11.03
- NFJ $11.89
- Analyst Decision
- BGM
- NFJ
- Analyst Count
- BGM 0
- NFJ 0
- Target Price
- BGM N/A
- NFJ N/A
- AVG Volume (30 Days)
- BGM 30.9K
- NFJ 223.5K
- Earning Date
- BGM 05-20-2025
- NFJ 01-01-0001
- Dividend Yield
- BGM N/A
- NFJ 9.01%
- EPS Growth
- BGM N/A
- NFJ N/A
- EPS
- BGM N/A
- NFJ N/A
- Revenue
- BGM $25,097,951.00
- NFJ N/A
- Revenue This Year
- BGM N/A
- NFJ N/A
- Revenue Next Year
- BGM N/A
- NFJ N/A
- P/E Ratio
- BGM N/A
- NFJ N/A
- Revenue Growth
- BGM N/A
- NFJ N/A
- 52 Week Low
- BGM $2.70
- NFJ $10.45
- 52 Week High
- BGM $14.78
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- BGM 50.51
- NFJ 58.32
- Support Level
- BGM $10.17
- NFJ $11.65
- Resistance Level
- BGM $11.82
- NFJ $11.90
- Average True Range (ATR)
- BGM 0.63
- NFJ 0.16
- MACD
- BGM -0.03
- NFJ 0.08
- Stochastic Oscillator
- BGM 54.21
- NFJ 98.84
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. Its primary investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.